Please login to the form below
statutory medicines
This page shows the latest statutory medicines news and features for those working in and with pharma, biotech and healthcare.
Life sciences leaders warn against ‘unworkable’ changes to UK medicines scheme
Over 20 life sciences leaders from companies supplying the NHS with essential medicines have united to warn against the ‘radical plans’ to change the statutory scheme for branded medicines. ... Without a new VPAS deal agreed upon, all sales of
Latest news
-
No further price cut for non-PPRS drugs in UK
But industry concerned over long-term plan for statutory medicines on the NHS. ... The DH announced in November 2013 that it would reduce the cost of these statutory medicines by 15% as part of wider drug pricing negotiations and there were concerns that
-
ABPI Code updates come into effect
There is also a grace period for the revised statutory scheme, which covers medicines that pharma companies choose to exclude from the voluntary, but more well-used. ... medicines). Bookings for these exams will be through a new website: http://exams.abpi
-
NHS medicine spend to remain flat for two years
to face a price cut on branded medicines to stick to the revised budget. ... In addition to the PPRS announcement, the DH also published details of its plans for statutory medicines - branded drugs sold by companies who do not sign up to the voluntary
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Brexit: can pharma 'take back control' of the narrative?
For example the sector has continued to see UK patients gaining slower and lower access to innovative medicines than other EU countries. ... Another example is the recent consultation on the Statutory Scheme for branded medicines, which seems to directly
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults
- Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO
- FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies
- Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
- New blood test to reduce heart attacks and death rates in A&E heart patients
- Clairvoyant commercialisation
No results were found
PMHub
SEVEN STONES COLLECTIVE
Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
